electroCore, Inc. (NASDAQ:ECOR - Free Report) - HC Wainwright boosted their FY2026 earnings per share (EPS) estimates for electroCore in a report issued on Wednesday, December 18th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings per share of $0.52 for the year, up from their prior estimate of $0.43. HC Wainwright has a "Buy" rating and a $25.00 price target on the stock. The consensus estimate for electroCore's current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore's FY2027 earnings at $1.34 EPS and FY2028 earnings at $2.24 EPS.
electroCore Stock Performance
Shares of NASDAQ ECOR traded down $0.95 during trading on Thursday, hitting $14.52. 284,662 shares of the company were exchanged, compared to its average volume of 36,781. The company has a fifty day moving average price of $11.51 and a 200-day moving average price of $8.12. The firm has a market capitalization of $95.18 million, a PE ratio of -7.93 and a beta of 0.57. electroCore has a 12-month low of $5.25 and a 12-month high of $17.84.
Institutional Trading of electroCore
A number of hedge funds and other institutional investors have recently made changes to their positions in ECOR. Renaissance Technologies LLC grew its position in electroCore by 3.4% in the second quarter. Renaissance Technologies LLC now owns 68,786 shares of the company's stock worth $442,000 after acquiring an additional 2,270 shares during the period. Geode Capital Management LLC grew its holdings in shares of electroCore by 10.3% during the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company's stock worth $458,000 after purchasing an additional 5,951 shares during the period. International Assets Investment Management LLC grew its holdings in shares of electroCore by 27.9% during the 2nd quarter. International Assets Investment Management LLC now owns 67,820 shares of the company's stock worth $436,000 after purchasing an additional 14,800 shares during the period. Finally, HighTower Advisors LLC acquired a new stake in shares of electroCore during the 3rd quarter worth about $255,000. Institutional investors and hedge funds own 26.74% of the company's stock.
About electroCore
(
Get Free Report)
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Further Reading
Before you consider electroCore, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and electroCore wasn't on the list.
While electroCore currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
